Literature DB >> 8714586

Clinical experience of management of thalassemia: the Sardinian experience.

A Cao1, R Galanello, M C Rosatelli, F Argiolu, S De Virgiliis.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8714586

Source DB:  PubMed          Journal:  Semin Hematol        ISSN： 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  6 in total

1.  Public perceptions and attitudes toward thalassaemia: Influencing factors in a multi-racial population.

Authors:  Li Ping Wong; Elizabeth George; Jin-Ai Mary Anne Tan
Journal:  BMC Public Health       Date:  2011-03-30       Impact factor: 3.295

2.  Beta thalassemia major in a developing country: epidemiological, clinical and evolutionary aspects.

Authors:  Mohamed Bejaoui; Naouel Guirat
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-01-02       Impact factor: 2.576

Review 3.  Sickle cell disease: a review for the internist.

Authors:  Valeria Maria Pinto; Manuela Balocco; Sabrina Quintino; Gian Luca Forni
Journal:  Intern Emerg Med       Date:  2019-08-05       Impact factor: 5.472

4.  Diethylentriaminepenta acetic acid glucose conjugates as a cell permeable iron chelator.

Authors:  Mona Mosayebnia; Mehdi Shafiee-Ardestani; Parvin Pasalar; Mojgan Mashayekhi; Massoud Amanlou
Journal:  J Pharmacol Pharmacother       Date:  2014-01

5.  Therapeutic value of combined therapy with deferasirox and silymarin on iron overload in children with Beta thalassemia.

Authors:  Adel A Hagag; Mohamed S Elfrargy; Rana A Gazar; Aml Ezzat Abd El-Lateef
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-11-04       Impact factor: 2.576

6.  Clinical Effect and Mechanism of Yisui Shengxue Granules in Thalassemia Patients with Mild, Moderate, or Severe Anemia.

Authors:  Yan-Ling Cheng; Xin-Hua Zhang; Yu-Wen Sun; Wen-Juan Wang; Su-Ping Fang; Zhi-Kui Wu
Journal:  Evid Based Complement Alternat Med       Date:  2016-02-02       Impact factor: 2.629
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.